TMPRSS2 and prostate carcinoma: Tomlins used FISH to evaluate the TMPRSS2:ETV1 fusion gene in paraffin sections of prostate cancer and found that, fusion signals were observed in an average of 31% of the 100 cancer cells in the positive case (Supporting Online Material page 3) (25).